Inner Banner

2024

Submitted by admin on Sat, 03/16/2024 - 15:30
Type
common
  1. Aradhye P, Jha S, Saha P, Raghavendra S. Patwardhan R, Noothalapati H, CM Krishna, Patwardhan S (2024). Distinct spectral signatures unfold ECM stiffness-triggered biochemical changes in breast cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 311: 123994. PMID: 38354672

  2. Arun B, Joshi M, Kakkar AK, Madki S, Ivaturi V, Chinnaswamy G, Banavali S, Gota V (2024). Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine. Pediatric Blood & Cancer. 71(3): e30813.PMID: 38110844

  3. Bathla P, Mujawar A, De A, Sandanaraj B (2024). Development of noninvasive activity-based protein profiling-bioluminescence resonance energy transfer platform technology enables target engagement studies with absolute specificity in living systems. ACS Pharmacology & Translational Science

  4. Biswas S, Anadon CM, Conejo-Garcia JR (2024). Antibodies target intracellular oncodrivers through PIGR-mediated transcytosis. Genes & Immunity. 25(1):85-86. PMID: 38092884.

  5. Chakraborty A, Mitra A, Sahu S, Tawate M, Lad S, Kamaldeep, Rakshit S, Upadhye Bannore T, Gaikwad S, Dhotre G, Ray MK, Damle A, Basu S, Banerjee S (2024). Intricacies in the preparation of patient doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab using low specific activity [177Lu]LuCl3: Methodological Aspects. Molecular Imaging and Biology. 26(1):61-80. PMID: 37673943

  6. Chatterjee G, Dhende P, Raj S, Shetty V, Ghogale S, Deshpande N, Girase K, Patil J, Kalra A, Narula G, Dalvi K, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR (2023). 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges. European Journal of Haematology. 112(1):122-136.PMID: 37706583

  7. Chatterjee S, Ganguly A, Bhattacharyya D (2024). Reprogramming nucleolar size by genetic perturbation of the extranuclear Rab GTPases Ypt6 and Ypt32. FEBS Letters.598 (3): 283-301. PMID: 37994551.

  8. Chaubal R, Gardi N, Joshi S, Pantvaidya G, Kadam R, Vanmali V, Hawaldar R, Talker E, Chitra J, Gera P, Bhatia D, Kalkar P, Gurav M, Shetty O, Desai S, Krishnan NM, Nair N, Parmar V, Dutt A, Panda B, Gupta S, Badwe R (2024). Surgical tumour resection deregulates Hallmarks of Cancer in resected tissue and the surrounding microenvironment. Molecular Cancer Research. PMID: 38394149.

  9. Chichra A, Nayak L, Kothari R, Kalantri S, Bonda A, Gokarn A, Punatar S, Mirgh S, Jindal N, Bagal B, Kannan S, Mathew L, Khattry N. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis. International Journal of Hematology. 119(1):71-79. PMID: 37952243.

  10. Colaco V, Goswami N, Goel VK, Srivastava SK, Lalrohlua P, Senthil Kumar N, Borah P, Baruah R, Varma AK (2024). In silico and structure-based evaluation of deleterious mutations identified in human Chk1, Chk2, and Wee1 protein kinase. Journal of Cellular Biochemistry. 125(1):89-99. PMID: 38047473.

  11. Dandia HY, Pillai MM, Sharma D, Suvarna M, Dalal N, Madhok A, Ingle A, Chiplunkar SV, Galande S, Tayalia P (2024). Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy. Military Medical Research.PMID: 38173045

  12. Desai S, Ahmad S, Bawaskar B, Rashmi S, Mishra R, Lakhwani D, Dutt A. Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. NAR Cancer. 6(1):zcae010. PMID: 38487301

  13. Dharavath B, Butle A, Chaudhary A, Pal A, Desai S, Chowdhury A, Thorat R, Upadhyay P, Nair S, Dutt A (2024). Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications. NPJ Precision Oncology. 8(1):63. PMID: 38438481.

  14. Digholkar G, Varghese R, Pal K, Sharma R (2024). Adipose-derived stem cells: an upcoming novel therapeutic in the management of Erectile dysfunction post radical prostatectomy in prostate cancer patients.International Journal of Impotence Research.PMID: 38443556

  15. Dixit J, Gupta N, Kataki A, Roy P, Mehra N, Kumar L, Singh A, Malhotra P, Gupta D, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S, Prinja S (2024). Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database. Health and Quality of Life Outcomes. 22(1):26

  16. Gadewal N, Natu A, Sen S, Rauniyar S, Bastikar V, Gupta S (2024). Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma.Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(5): 130596. PMID: 38471632

  17. Gardi NL, Chaubal R, Parab P, Pachakar S, Kulkarni SS, Shet T, Joshi S, Kembhavi Y, Chandrani P, Quist J, Kowtal P, Grigoriadis A, Sarin R, Govindrajan R, Gupta S (2024). Natural history of germline BRCA1 mutated and BRCA wild-type triple-negative breast cancer. Cancer Research Communications PMID: 38315150.

  18. Gaur T, Ali A, Sharma D, Gupta SK, Gota V, Bagal B, Platzbeckar U, Mishra R, Dutt A, Khattry N, Mills K, Hassan Md., Sandur S, Hasan SK (2024). Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. Cellular Signalling. 14: 111004.PMID: 38048856

  19. Ghosh S, Goda J, Chatterjee A, Shetty P,Sahay A, Dasgupta A, Epari S, Sahu A, Singh V, Gupta T, Moiyadi A, Jalali R. Clinical outcomes following surgery and radiation therapy in a real world setting. World Neurosurgery. 181:e809-e819. PMID: 37923012.

  20. Gupta SK, Gohil D, Momin MB, Yadav S, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Hingorani L, Khattry N, Gota V (2024). Withania somnifera extract mitigates experimental acute graft versus host disease without abrogating graft versus leukemia effect. Cell Transplantation. 33:9636897241226573. PMID: 38258793.

  21. Gupta T, Chatterjee A (2024). Existing and evolving landscape of medulloblastoma: Towards optimization and personalization. Diagnostics. 14(6): 598.

  22. Hande V, Ranjan N, Chopra S, Sinha S, Mittal P, Gupta A, Maheshwari A, Gupta S (2024). Longitudinal costs of image-guided intensity-modulated radiation therapy versus three-dimensional conformal radiation: Lessons from phase III PARCER trial for shaping resource-stratified guidelines in low- and middle-income countries. JCO Global Oncology. PMID: 38484193

  23. Huck C, Achard V, Maitre P, Murthy V, Zilli T (2024). Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies. Clinical and Translational Radiation Oncology. 45: 100709.

  24. Jadhav P, Hole A, Sivaprasad M, Viswanath K, Sahay M, Sahay R, Reddy GB, CM Krishna (2024). Raman spectroscopy analysis of plasma of diabetes patients without and with retinopathy, nephropathy, and neuropathy. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy. 304:123337. PMID: 37703793

  25. Jadhav PA, Hole A, Ingle A, Govekar R, Noothalapati H, Krishna CM (2024). Serum Raman spectroscopy: Evaluation of tumour load variations in experimental carcinogenesis. Journal of Biophotonics. PMID: 38229194.

  26. Jindal N, C M, Mathew LJ, Kumbhalwar K, Patel K, Garg M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Khattry N (2024. Fertility outcomes in patients desiring conception following autologous stem cell transplantation for hodgkin lymphoma using LACE conditioning. Bone Marrow Transplantation. 59: 417–418. PMID: 38102211.

  27. Kadam S, Jadhav P, Singh R, Hole A, Sawardekar S, CM Krishna, Barage S (2024). Raman spectroscopic characterization of local rice germplasm from konkan region of Maharashtra. Food Analytical Methods.

  28. Khanna D, Sharma P, Budukh A, Vishwakarma R, Sharma AN, Bagal S, Tripathi V, Maurya VK, Chaturvedi P, Pradhan S. Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry. BMC Cancer. 2024 Mar 6;24(1):308. PMID: 38448839.

  29. Kumar S, Castelino R, Rao A, Gattani S, Kumar A, Pillai A, Sehgal A, Rane P, Ramaswamy A, Dhekale R, Krishnamurthy J, Banavali S, Badwe R, Prabhash K, Noronha V, Gota V (2024). Performance of potentially inappropriate medications assessment tools in older Indian patients with cancer. Cancer Medicine.13(1):e6797. PMID: 38183404

  30. Laibl S, André F, Bachelot T...Guarneri V, Gupta S...Harbeck N on behalf of the ESMO Guidelines Committe (2024). Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 35(2):159-182. PMID: 38101773

  31. Lokhande M, Kannusamy S, Oak A, Cheulkar S, Chavan S, Mishra V, Gode P, Thakadiyil AS, Mendhe S, Kadam S, Balasubramaniam G, Chaturvedi P, Dikshit R (2024). A hospital-based study of survival in oral cancer patients of Tata Memorial Hospital, Mumbai. Ecancermedicalscience. 18:1669. PMID: 38439812

  32. Mani S, Chatterjee A, Dasgupta A, Shirsat N, Pawar A, Epari S, Sahay A, Sahu A, Moiyadi A, Prasad M, Chinnaswamy G, Gupta T (2024). Clinico-Radiological Outcomes in WNT-Subgroup Medulloblastoma. Diagnostics (Basel). 14(4):358. PMID: 38396397

  33. Manikandan M, Chhatar S, Gadre S, Paul S, Vaidya SP, Khatri S, Duari P, Kode J, Ingle A, Kolthur-Seetharam U, Patra M (2023). Improving in vivo tumor accumulation and efficacy of platinum antitumor agents by electronic tuning of the kinetic lability. Chemistry- A European Journal. 30(4): e202302720. PMID: 37888749.

  34. McLeod M, Torode J, Leung K, Bhoo-Pathy N, Booth C, Chakowa J, Gralow J, Ilbawi A, Jassem J, Parkes J, Mallafré-Larrosa M, Mutebi M, Pramesh CS, Sengar M, Tsunoda A, Unger-Saldaña K, Vanderpuye V, Yusuf A, Sullivan R, Aggarwal A (2024). Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study. Lancet Oncology. 25(2):e63-e72.PMID: 38301704

  35. Mirian C, Jensen LR, Juratli TA, Maier AD, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Bertero L, Stummer W, Spille DC, Brokinkel B, Oya S, Miyawaki S, Saito N, Proescholdt M, Kuroi Y, Gousias K, Simon M, Moliterno J, Prat-Acin R, Goutagny S, Prabhu VC, ...Jensen R, Gupta T...et al. The importance of considering competing risks in recurrence analysis of intracranial meningioma. Journal of Neurooncology. 166(3):503-511. PMID: 38336917.

  36. Mishra N, Dubey S, Kumari A, Khan MA, Kuligina ES, Preobrazhenskaya EV, Romanko AA, Yadav LR, Sarin R, Imyanitov EN, Varma AK (2024). Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h-BRCA1. Proteins. 92(4):540-553. PMID: 38037760.

  37. Mishra SV, Banerjee A, Sarkar D, Thangarathnam V, Bagal B, Hasan SK, Dutt S (2024). DNA-PKcs mediated transcriptional regulation of TOP2β drives chemoresistance in acute myeloid leukemia. Journal of Cell Science. PMID: 38240344

  38. Mittra I (2024). Exploiting the damaging effects of ROS for therapeutic use by deactivating cell-free chromatin: The alchemy of resveratrol and copper. Frontiers in Pharmacology.

  39. Mohamad O, Zamboglou C, Zilli T, Murthy V, Aebersold D, Loblow A, Guckenberger M, Shelan M (2023). Safety of ultra-hypofractionated pelvic nodal irradiation in the definitive management of prostate cancer: Systematic review and meta-analysis. International Journal of Radiation Oncology, Biology, Physics. 118(4):998-1010.PMID: 37863241

  40. Mohanty S, Patil D, Joshi K, Gamre P, Mishra A, Khairnar S, Kakoti S, Nayak L,Punatar S, Jain J, Phurailaptam R, Goda J (2024). Dosimetric impact of voluntary Deep Inspiration Breath Hold (DIBH) in mediastinal hodgkin lymphomas: A comparative evaluation of three different Intensity Modulated Radiation Therapy (IMRT) delivery methods using voluntary DIBH and free breathing techniques. Cancers. 16(4): 690. PMID: 38398081

  41. Moharir S, Akotkar L, Aswar U, Kumar D, Gawade B, Pal K, Rane R (2024). Improved pharmacokinetic and pharmacodynamic profile of deuterium-reinforced tricyclic antidepressants doxepin, dosulepin, and clomipramine in animal models. European Journal of Drug Metabolism and Pharmacokinetics. PMID: 38172422

  42. Mujawar A, Dimri S, Palkina KA, Markina NM, Sarkisyan KS, Balakireva AV, Yampolsky IV, De A (2024). Novel BRET combination for detection of rapamycin-induced protein dimerization using luciferase from fungus Neonothopanusnambi. Heliyon10(4): e25553. PMID: 38384550

  43. Natu A, Verma T, Khade B, Thorat R, Gera P, Dhara S, Gupta S (2024). Histone acetylation: A key determinant of acquired cisplatin resistance in cancer. Clinical Epigenetics. 16:8. PMID: 38172984

  44. Natu K, Dutta S, Bose K (2024). cFLIP – An interacting partner and a novel substrate for pro-apoptotic serine protease HtrA2. Biochemistry and Biophysics Reports. 38: 101682

  45. Ndarukwa S, Flores JA, Rosenblatt E, Berger D, Akbarov K, Hedden N, Chopra S, Hande V, Rubio AP (2024). Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients with Cervical Cancer and Impact on IGBT Implementation-An IAEA Study. JCO Global Oncology. PMID: 38386958.

  46. Nofal M, Zhuang A, Gebeyehu N, ...Alito T, Ambulkar R. etal. (Clean Cut Investigation Group) (2024). An observational cohort study on the effects of extended postoperative antibiotic prophylaxis on surgical-site infections in low- and middle-income countries. British Journal of Surgery. 111(1): znad438. PMID: 38198157"

  47. Noronha V, Dhanawat A, Patil VM, Menon N, Singh AK, Chaturvedi P, Pai P, Chaukar D, Laskar SG, Prabhash K (2024). Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice. Oral Oncology. 148:106633. PMID: 37988838.

  48. Noronha V, Kapu V, Joshi A, Menon N, Singh A, Prakash G, Menon S, Sable N, Murthy V, Pal M, Arora A, Kumar S, Banavali S, Prabhash K (2024). Clinical profile and outcomes of carcinoma penis patients receiving systemic therapy at an Indian tertiary care centre: A retrospective observational study. Clinical Genitourinary Cancer.

  49. Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, Singh A, Peelay Z, Chakraborty S, Jadhav M, Alone M, Bhagyavant P, Kolkur M, Srinivas S, Das S, Roy S, Mandal T, Dsouza H, Saha S, Rai R, Srikanth A, Shah D, Khan A, Muthuluri H, Kumar A, Agarwal A, Rajpurohit A, Goli V, Sekar A, Mantri A, Kanteti A, Majumdar S, Khaddar S, Shenoy R, Elamarthi P, Rathnaswamy N, Kashyap L, Abraham G, Booma N, Simha V, Chaukar D, Pai P, Nair S, Laskar S, Nawale K, Naidu P, Salian S, Shelar P, Raulo R, Dhumal S, Prabhash K (2024).Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer. 200: 113560. PMID: 38306841

  50. Patwardhan RS, Gohil D, Singh B, Kumar BK, Purohit V, Thoh M, Checker R, Gardi N, Gota V, Kutala VK, Patwardhan S, Sharma D, Sandur SK (2024). Mitochondrial-targeted curcumin inhibits T-cell activation via Nrf2 and inhibits graft-versus-host-disease in a mouse model. Phytotherapy Research. PMID: 38281735.

  51. Qureshi S, Reddy S, Smriti V, Baheti A, Shah S, Channaswamy G, Prasad M, Parambil B, Gollamudi V, Panjwai P, Ramadwar M, Amin N, Kembhavi S (2024). Impact of surgical timing (primary, delayed, or second look) on surgical morbidity and outcomes in Malignant Germ Cell Tumor of the Ovary in children. Journal of Pediatric Surgery

  52. Raghuram GV, Pal K, Sriram G, Khan A, Joshi R, Jadhav V, Shinde S, Shaikh A, Rane B, Kangne H, Mittra I. Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes. PLoS One. 19(2): e0298042. PMID: 38346047.

  53. Raghuram GV, Tripathy BK, Avadhani K, Shabrish S, Khare NK, Lopes R, Pal K, Mittra I (2024). Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells. Cell Death Discovery. PMID: 38225229.

  54. Rai A, Patwardhan R, Jayakumar S, Pachpatil P, Das D, Panigrahi G, Gota V, Sandur S (2024). Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis. Acta Pharmacologica Sinica. PMID: 38480835

  55. Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, Sahu A, Shetty P, Moiyadi A, Singh V, Dasgupta A, Chatterjee A, Kannan S, Gupta T (2024). CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. Journal of Neuro-oncology. PMID: 38265748.

  56. Ranganathan S, Dee EC, Debnath N, Patel TA, Jain B, Murthy V. Access and barriers to genomic classifiers for breast cancer and prostate cancer in India. International Journal of Cancer. 154(8): 1335-1339. PMID: 37962056.

  57. Rao A, Noronha V, Ramaswamy A, Kumar A, Pillai A, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekle R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe R, Prabhash K (2023). Correlation of the geriatric assessment with overall survival in older patients with cancer. Clinical Oncology. 36(1): e61-e71PMID: 37953073

  58. Rao AR, Noronha V, Ramaswamy A, Kumar A, Pillai A, Sehgal A, Castelino R, Dhekale R, Jagtap P, Tripathi V, Satamkar S, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe RA, Prabhash K. Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival. Journal of Geriatric Oncology. 15(3):101736. PMID: 38428186.

  59. Sandhbhor P, Palkar P, Bhat P, Bhat S, John G, Goda J (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale

  60. Sengupta S, Biswas M, Gandhi KA, Gupta SK, Gera PB, Gota V, Sonawane A (2024). Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia. Translational Oncology. PMID: 38412663.

  61. Sharma H, Bhuyan M, Natu K, Sahoo D, Bose K, Mishra R, Poddar N (2024). Effect of proline-functionalized zinc oxide (ZnOP) as nano-osmolyte on bovine serum albumin (BSA). Frontiers in Pharmacology.

  62. Shetty T, Joshi P, Talole S, Nair S, Chaturvedi P (2024). Factors affecting drain output in oral carcinoma. Journal of Maxillofacial and Oral Surgery.

  63. Shinde U, De A, Godse R, Rathod M, Thorat R, Sharma N, Ansari M, Singh K (2024). Efficacy evaluation of carboplatin -etoposide Co-loaded PLGA microparticles for subconjunctival chemotherapy in retinoblastoma. Journal of Drug Delivery Science and Technology. 92: 105333.

  64. Shivshankar S, Mhamane S, Budukh AM (2024). Representation of Indian and Chinese cancer registries from 1964 to 2017 in Cancer Incidence in Five Continents: Growing burden but low coverage. International Journal of Cancer. PMID: 38357961.

  65. Shivshankar S, Sarade M, Bhojane S, Kolekar S, Patil S, Budukh A. Quality assessment of a rural population-based cancer registry (PBCR) at Ratnagiri, Maharashtra, India for the years 2017-18. Ecancermedicalscience. 18:1672. PMID: 38439807

  66. Shruti T, Sharma P, Budukh A, Khanna D (2024). Electronic nicotine delivery system: a narrative review on growing threat to tobacco control and health of the young Indian population. International Journal of Adolescent Medicine and Health. PMID: 38369380

  67. Sinha S, Kumar A, Maheshwari G, Mohanty S, Joshi K, Shinde P, Gupta D, Kale S, Phurailatpam R, Swain M, Budrukkar A, Kinhikar R, Ghosh-Laskar S (2024). Development and validation of single-optimization knowledge-based volumetric modulated arc therapy model plan in nasopharyngeal carcinomas. Advances in Radiation Oncology. 9 (1): 101311. PMID: 38260222

  68. Soares A, Bourlon MT, Wong A, Joshi A, Jardim D, Korbenfeld E, Karak FE, Orlandi F, Sze H, Ansari J, Zarba J, Mansour MA, Manneh R, Thirumulai R, Tsai YC, Morsi WA, Powles T. Management of metastatic urothelial carcinoma in Emerging Markets (EM): An expert opinion. Clinical Genitourinary Cancer. PMID: 38228413.

  69. Srinivasan S, Dhamne C, Patkar N, Chatterjee G, Moulik NR, Chichra A, Pallath A, Tembhare P, Shetty D, Subramanian PG, Narula G, Banavali S (2023). KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1. Pediatric Blood Cancer. 71(2): e30791. PMID: 38014874.

  70. Srinivasan S, Keerthivasagam S, Kumar S, Puri A (2024). ASO Author Reflections: Utilizing surveillance imaging techniques for detecting recurrences in patients with extremity sarcomas. Annals of Surgical Oncology. 31(3):2063-2064.PMID: 37851198

  71. Swain M, Budrukkar A, Murthy V, Pai P, Kanoja A, Ghosh-Laskar S, Dushmukh A, Pantvaidya G, Kannan S, Patil V, Noronha V, Prabhash K, Sinha S, Kumar A, Gupta T, Agarwal J (2024). Contralateral nodal relapse in well lateralized oral cavity cancers treated uniformly with ipsilateral surgery and adjuvant radiotherapy with or without concurrent chemotherapy: A retrospective study. Clinical Oncology. PMID: 38365518

  72. Talati VP, Karn V, Gadewal N, Bastikar VA (2024). Mechanistic influence of discreet conformation of human telomerase linker region. Journal of Biomolecular Structure and Dynamics. PMID: 38319038.

  73. Thorat J, Bhat S, Sengar M, Baheti A, Bothra S, Bhaskar M, Tandon SP, Biswas SK, Salunke GV, Karimundackal G, Tiwari VK, Pramesh CS, Sharma N, Kapu V, Eipe T, Bagal BP, Nayak L, Bonda A, Janu A, Shetty A, Jain H (2024). Clinical utility of stepwise bronchoalveolar lavage fluid analysis in diagnosing and managing lung infiltrates in leukemia/lymphoma patients with febrile neutropenia. JCO Global Oncology. PMID: 38301183.

  74. Verma A, Patel R, Mahale A, Thorat RV, Rath SL, Sridhar E, Moiyadi A, Srivastava S (2024). Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing. OMICS: A Journal of Integrative Biology.28(2):59-75. PMID: 38320249.

  75. Wadasadawala T, Mohanty S, Sen S, Kanala T, Maiti S, Puchali N, Gupta S, Sarin R, Parmar V (2024). Out-of-pocket payment and financial risk protection for breast cancer treatment: prospective study from India. The Lancet Regional Health- Southeast Asia.

Select Year
order
0
Back to Top